Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Net Asset Value - Dividend Investment Scheme

26 Apr 2023 11:39

RNS Number : 5562X
Maven Income and Growth VCT 5 PLC
26 April 2023
 

Maven Income and Growth VCT 5 PLC

 

Net Asset Value (NAV) - Dividend Investment Scheme (DIS)

 

The Board of Maven Income and Growth VCT 5 PLC (the Company) has announced previously that the NAV per share of the Company as at 28 February 2023 was 35.45p and that a final dividend of 0.50p per share in respect of the year ended 30 November 2022 would be paid on 5 May 2023, to Shareholders on the register at close of business on 31 March 2023. Furthermore, in respect of Shareholders who had, by no later than 19 April 2023, elected to participate in the DIS, the Company will use the amount paid in respect of the above final dividend to subscribe for new ordinary shares of 10p each in the Company (Ordinary Shares) to be issued at a price equivalent to the latest announced NAV per share.

 

The Board confirms that, following the payment of the above dividend, the effective NAV per share of the Company is 34.95p and that this will be the price used in the calculation of the number of Ordinary Shares to be allotted under the DIS in respect of the final dividend, the issue of which will be confirmed in a separate announcement in due course.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

26 April 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUNORROBUSUAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.